Scott is Director of the Antibody Therapeutics group at GNF. His group is responsible for a broad range of platform activities associated with early to late stage antibody drug discovery. Prior to joining GNF, Scott was Sr. Director and Site Head for Pfizer’s Centers for Therapeutic Innovation (CTI) in La Jolla and had positions of increasing responsibility in the nine years prior at Biogen Idec where he was Director of Antibody Therapeutics. Scott received his Ph.D. in Molecular Biology and Biochemistry from UC Irvine and his B.A. from UC San Diego. He completed his post-doctoral training at Protein Design Labs in Mountain View, CA.